Fundamentals-based quality & risk · not a recommendation
Eternal Ltd scores 41/100 (Caution) on the Orion Score — poor business quality (13), strong growth (99) and weak balance-sheet safety (46). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
56/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹17,292 | ₹174 | 0.1% | ₹0.19 |
| Q3 2026 | ₹16,315 | ₹102 | -0.4% | ₹0.11 |
| Q1 2026 | ₹7,167 | ₹25 | -2.8% | ₹0.03 |
| Q4 2025 | ₹5,833 | ₹39 | -3.7% | ₹0.04 |
| Q3 2025 | ₹5,405 | ₹59 | -1.6% | ₹0.06 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2025 | ₹20,243 | ₹527 | ₹1,711 | 0.1% |
| FY 2024 | ₹12,114 | ₹351 | ₹886 | -2.9% |
| FY 2023 | ₹7,035 | ₹-971 | ₹-532 | -22.5% |
| FY 2022 | ₹4,119.6 | ₹-1,208.7 | ₹-1,060 | -49.7% |
Top companies in the same sector by market cap
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹35,623 | ₹23,356 | ₹21,599 | ₹17,327 |
| Equity | ₹30,317 | ₹20,413 | ₹19,460 | ₹16,505.5 |
| Total Debt | ₹2,045 | ₹749 | ₹507 | ₹70.3 |
| Cash | ₹666 | ₹309 | ₹218 | ₹392.3 |
| Net Debt | — | — | — | — |
| Working Capital | ₹8,375 | ₹3,375 | ₹9,390 | ₹6,833.5 |
Q1 FY2027
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q1 FY2027 | 27.2% ↓ | 28.26% ↑ | 23.12% ↑ | 21.42% ↑ |
| Q4 FY2026 | 27.75% | 28.04% | 22.95% | 21.26% |
No recent corporate actions
Q4 FY2025
| Investor | Shares Held | Portfolio % | Change |
|---|---|---|---|
| goldman-sachs | — | 2.40% | — |
Ask: "Is Eternal Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.